Sold 2 Credit Spreads on Atossa Therapeutics Inc (NASDAQ:ATOS) – 15.3% potential income return in 31 days
On June 15, 2021, I sold 2 bull put credit spreads on ATOS stock with an expiry set in the next 31 days. For this trade, we got a $122.40 premium (after commissions)
Atossa Therapeutics is a clinical-stage biopharmaceutical company focusing on breast cancer treatment and other breast conditions.
The current stock price and options premium for ATOS stock, kind of reminds me of BCRX stock a year ago, which I traded a lot in 2020.
This is the reason I entered this trade - a sentiment for a volatile biotech stock. lol
Here is our trade setup:
BOT 2 ATOS JUL 16 '21 - 4 + 2.5 Put Bull Spread -0.66 USD
For this trade, we got a premium of 122.40 USD (after commissions) or 15.3% potential income return in 31 days (if options expire worthlessly)
What happens next?
On the expiry date (July 16, 2021) ATOS is trading above $4 per share - options expire worthlessly and we keep premium, realizing our max potential from this trade. If ATOS trades under $4 on the expiry date, we get assigned.
But as we already have collected a premium of $0.61 per share, our break-even price for this trade then is $4-$0.61= $3.39
If assigned - will sell covered calls
As we are selling credit spreads, our max risk is defined, in case the stock will drop below $2.5, our second bought put will work as insurance and will minimize our potential losses.
Create your profile
Only paid subscribers can comment on this post
Check your email
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.